- Home
- OWL vs WST Comparison
OWL vs WST Comparison
Compare OWL & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OWL
- WST
- Stock Information
- Founded
- OWL 2020
- WST 1923
- Country
- OWL United States
- WST United States
- Employees
- OWL N/A
- WST N/A
- Industry
- OWL Investment Managers
- WST Medical/Dental Instruments
- Sector
- OWL Finance
- WST Health Care
- Exchange
- OWL Nasdaq
- WST Nasdaq
- Market Cap
- OWL 11.5B
- WST 15.2B
- IPO Year
- OWL N/A
- WST N/A
- Fundamental
- Price
- OWL $18.48
- WST $213.06
- Analyst Decision
- OWL Buy
- WST Strong Buy
- Analyst Count
- OWL 15
- WST 6
- Target Price
- OWL $24.23
- WST $349.00
- AVG Volume (30 Days)
- OWL 9.1M
- WST 977.3K
- Earning Date
- OWL 05-01-2025
- WST 04-24-2025
- Dividend Yield
- OWL 4.86%
- WST 0.39%
- EPS Growth
- OWL 23.81
- WST N/A
- EPS
- OWL 0.16
- WST 6.37
- Revenue
- OWL $2,465,573,000.00
- WST $2,895,800,000.00
- Revenue This Year
- OWL $21.89
- WST $1.24
- Revenue Next Year
- OWL $20.05
- WST $6.56
- P/E Ratio
- OWL $117.52
- WST $33.62
- Revenue Growth
- OWL 32.99
- WST N/A
- 52 Week Low
- OWL $14.55
- WST $187.43
- 52 Week High
- OWL $26.73
- WST $372.79
- Technical
- Relative Strength Index (RSI)
- OWL 50.69
- WST 48.76
- Support Level
- OWL $17.77
- WST $204.79
- Resistance Level
- OWL $18.71
- WST $221.42
- Average True Range (ATR)
- OWL 0.61
- WST 7.01
- MACD
- OWL 0.16
- WST 1.16
- Stochastic Oscillator
- OWL 78.29
- WST 56.77
About OWL Blue Owl Capital Inc.
Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.